Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on September 18, 2026

Sep. 18, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

First Atlantic Nickel & Cobalt Raises 6.15 Million Dollars in No-Warrant, Non-Brokered Private Placement to Accelerate Mining Exploration and Development at Pipestone XL Nickel-Cobalt Alloy (Awaruite) Project in Newfoundland

Indeterminate GlobeNewswire

Sep. 18, 2026

Bastion Receives Conditional OCC Approval for a National Trust Bank Charter

Indeterminate GlobeNewswire

Sep. 18, 2026

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

Indeterminate GlobeNewswire

Sep. 18, 2026

NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update

Indeterminate GlobeNewswire

Sep. 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Omega Flex, Inc. Announces Regular Quarterly Dividend for the Third Quarter 2026

Indeterminate GlobeNewswire

Sep. 18, 2026

Enact Receives Ratings Upgrade from AM Best

Indeterminate GlobeNewswire

Sep. 18, 2026

XCharge Reports First Half 2026 Unaudited Financial Results

Indeterminate GlobeNewswire

Sep. 18, 2026

Phoenix Energy Announces Distribution for Preferred Shares

Indeterminate GlobeNewswire

Sep. 18, 2026

Peptide Review Hub Opens Vendor Registration for Research Suppliers

Indeterminate EIN Presswire

Sep. 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Amneal Announces FDA Approval and Launch of Lanreotide Injection

Indeterminate GlobeNewswire

Sep. 18, 2026

The Surrey Institute of Clinical Hypnotherapy Launches Free Tool to Reveal Hidden Anxiety Patterns

Indeterminate EIN Presswire

Sep. 18, 2026

Pemi Named Best Perimenopause Supplement Brand of 2026

Indeterminate GlobeNewswire

Sep. 18, 2026

FLUENCE ENERGY, INC. INVESTIGATION: FLNC Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

Indeterminate GlobeNewswire

Sep. 18, 2026

Olorama’s scent technology supports new research on memory and virtual reality by KITE Research Institute

Indeterminate EIN Presswire